Aripiprazole for the treatment of schizophrenia with co-morbid social anxiety.
Phase of Trial: Phase IV
Latest Information Update: 03 Jun 2015
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 30 Jan 2007 Status changed from recruting
- 27 Nov 2005 New trial record.